Patient Square Capital LP Diversified Active

Location: Menlo Park, CA

CIK: 0001819257 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $564M (100.0% shares, 0.0% debt)

Holdings (29)

ROIV ROIVANT SCIENCES LTD 40.1%
Value $226M Shares 8,166,047 Est. Cost $7.21 Unrealized +235.1%
ARGX ARGENX SE 4.8%
Value $26.81M Shares 36,718 Est. Cost $686.33 Unrealized
INSM INSMED INC 4.6%
Value $25.75M Shares 157,500 Est. Cost $73.51 Unrealized +116.3%
ONC BEONE MEDICINES LTD 4.2%
Value $23.92M Shares 80,542 Est. Cost $302.86 Unrealized
COGT COGENT BIOSCIENCES INC 4.1%
Value $22.94M Shares 596,000 Est. Cost $32.44 Unrealized +15.2%
MIRM MIRUM PHARMACEUTICALS INC 3.8%
Value $21.25M Shares 230,000 Est. Cost $62.11 Unrealized +55.5%
BLTE BELITE BIO INC 3.3%
Value $18.6M Shares 116,684 Est. Cost $159.44 Unrealized
LEGN LEGEND BIOTECH CORP 3.2%
Value $17.91M Shares 990,000 Est. Cost $18.09 Unrealized
NKTR NEKTAR THERAPEUTICS 2.7%
Value $15.11M Shares 210,000 Est. Cost $48.33 Unrealized 0.0%
DBVT DBV TECHNOLOGIES S A 2.6%
Value $14.49M Shares 693,534 Est. Cost $20.00 Unrealized
PHVS PHARVARIS N V 2.5%
Value $13.93M Shares 493,000 Est. Cost $21.02 Unrealized +27.2%
ABVX ABIVAX SA 2.4%
Value $13.5M Shares 121,245 Est. Cost $84.90 Unrealized
XENE XENON PHARMACEUTICALS INC 2.3%
Value $13.2M Shares 227,000 Est. Cost $41.99 Unrealized -0.0%
CELC CELCUITY INC 1.9%
Value $10.84M Shares 95,000 Est. Cost $47.06 Unrealized +128.4%
EYPT EYEPOINT INC 1.8%
Value $10.25M Shares 795,000 Est. Cost $8.84 Unrealized +72.2%
MRK MERCK & CO INC 1.7%
Value $9.623M Shares 80,000 Est. Cost $114.28 Unrealized 0.0%
ARQT ARCUTIS BIOTHERAPEUTICS INC 1.7%
Value $9.439M Shares 400,645 Est. Cost $26.20 Unrealized +2.5%
ALLO ALLOGENE THERAPEUTICS INC 1.5%
Value $8.418M Shares 3,450,000 Est. Cost $1.76 Unrealized -1.0%
KYMR KYMERA THERAPEUTICS INC 1.5%
Value $8.329M Shares 100,000 Est. Cost $46.83 Unrealized +65.7%
DNTH DIANTHUS THERAPEUTICS INC 1.4%
Value $7.879M Shares 93,882 Est. Cost $27.76 Unrealized +71.4%
ELVN ENLIVEN THERAPEUTICS INC 1.4%
Value $7.84M Shares 200,000 Est. Cost $23.51 Unrealized +8.9%
CATX PERSPECTIVE THERAPEUTICS INC 1.2%
Value $6.776M Shares 1,625,000 Est. Cost $3.32 Unrealized +15.6%
DFTX DEFINIUM THERAPEUTICS INC 1.1%
Value $6.256M Shares 331,000 Est. Cost $16.29 Unrealized 0.0%
HROW HARROW INC 1.0%
Value $5.825M Shares 165,209 Est. Cost $47.86 Unrealized +0.5%
TARA PROTARA THERAPEUTICS INC 1.0%
Value $5.371M Shares 1,030,846 Est. Cost $6.18 Unrealized 0.0%
CTMX CYTOMX THERAPEUTICS INC. 0.9%
Value $5.103M Shares 1,085,790 Est. Cost $5.23 Unrealized 0.0%
RCUS ARCUS BIOSCIENCES INC 0.7%
Value $4.212M Shares 195,000 Est. Cost $20.51 Unrealized +3.7%
ASMB ASSEMBLY BIOSCIENCES INC 0.7%
Value $3.783M Shares 136,315 Est. Cost $22.39 Unrealized +27.3%
SYRE SPYRE THERAPEUTICS INC 0.0%
Value $50,440 Shares 1,000 Est. Cost $26.13 Unrealized +32.2%